Endeavor

Does CAR T Show Promise for Solid Tumors?

Dr. Patrick Hwu tackles the topic in this episode of the Moffitt Medical Minute

Can Gene-Edited CAR T Improve Non-Hodgkin Lymphoma Outcomes?

New product involves dual targeting, signaling technology and gene editing

Can mRNA Vaccines Boost Effectiveness of CAR T-Cell Therapy?

Early trial results show response in solid tumors

Comedian Louie Anderson Dead at 68

He was undergoing treatment for non-Hodgkin lymphoma

Health Status, not Age, Should Determine CAR T Eligibility

Moffitt study outlines factors doctors should consider when recommending cellular therapy

Highlighting Moffitt’s Top 5 Research Stories of 2021

FDA approvals and COVID vaccine in cancer patients study showcase ability to translate discoveries into new therapies

UltraCAR-T™ Shows Promise for Treating Myeloid Malignancies

Fast-acting treatment aims to extend lives when minutes matter

Moffitt Study Shows Benefit to Giving CAR T-cell Therapy to Patients Sooner

Using cell therapy as a second-line treatment provided better outcomes for lymphoma patients compared to standard of care

Does Intensifying Lymphodepletion Impact CAR T-Cell Therapy?

Study investigates increasing duration and dosage of chemotherapy in patients with B-cell malignancies